PUBLISHER: TechNavio | PRODUCT CODE: 1911256
PUBLISHER: TechNavio | PRODUCT CODE: 1911256
The global exosome therapeutics market is forecasted to grow by USD 408620.8 thousand during 2025-2030, accelerating at a CAGR of 19.6% during the forecast period. The report on the global exosome therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasingly sophisticated and scalable manufacturing technologies, expanding clinical pipeline and broadening therapeutic applications, growing investment and evolving regulatory framework.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 17% |
| CAGR | 19.6% |
| Incremental Value | $408620.8 thousand |
Technavio's global exosome therapeutics market is segmented as below:
By Application
By Distribution Channel
By Type
Geography
This study identifies the expansion of exosomes as drug delivery systems as one of the prime reasons driving the global exosome therapeutics market growth during the next few years. Also, rising partnerships and collaborations between companies and healthcare organisations and artificial exosomes for translational nanomedicine will lead to sizable demand in the market.
The report on the global exosome therapeutics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global exosome therapeutics market vendors that include Aegle Therapeutics, AMS Biotechnology Europe Ltd., Aruna Bio Inc., Capricor Therapeutics Inc., CIloa SAS, Creative Biolabs, Cytiva, Direct Biologics LLC, Evotec SE, Evox Therapeutics Ltd., ExoCoBio Inc., ILIAS Biologics Inc., Lonza Group Ltd., NanoFCM Co. Ltd, ReNeuron Group plc, Rion Inc., Thermo Fisher Scientific Inc.. Also, the global exosome therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.